These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29543791)

  • 41. Update on vaccine-derived polioviruses.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(40):1093-7. PubMed ID: 17035927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment.
    Alleman MM; Wannemuehler KA; Weldon WC; Kabuayi JP; Ekofo F; Edidi S; Mulumba A; Mbule A; Ntumbannji RN; Coulibaly T; Abiola N; Mpingulu M; Sidibe K; Oberste MS
    J Infect Dis; 2014 Nov; 210 Suppl 1():S62-73. PubMed ID: 25316879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey.
    Alfonso VH; Voorman A; Hoff NA; Weldon WC; Gerber S; Gadoth A; Halbrook M; Goldsmith A; Mukadi P; Doshi RH; Ngoie-Mwamba G; Fuller TL; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    BMC Infect Dis; 2022 Jan; 22(1):30. PubMed ID: 34986786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria.
    Lorenzetti L; Haydarov R; Namey E; Lawton A; Nam H; Ridwan Hasan M; Monj C; Abeyesekera S; Amina Kabwau M; McIntosh R
    Vaccine; 2023 Apr; 41 Suppl 1():A128-A135. PubMed ID: 35871107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress toward interrupting wild poliovirus circulation in countries with reestablished transmission--Africa, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(10):306-11. PubMed ID: 21412212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon.
    Endegue-Zanga MC; Sadeuh-Mba SA; Iber J; Burns C; Nimpa-Mengouo M; Demanou M; Vernet G; Etoa FX; Njouom R
    J Clin Virol; 2015 Jan; 62():80-3. PubMed ID: 25542478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction Model with Validation for Polioseronegativity in Malnourished Children from Poliomyelitis Transmission High-Risk Area of the Democratic Republic of the Congo (DRC).
    Mwamba GN; Kabamba M; Hoff NA; Mukadi PK; Musene KK; Gerber SK; Halbrook M; Sinai C; Fuller T; Voorman A; Mawaw PM; Numbi OL; Wemakoy EO; Mechael PN; Tamfum JJM; Mapatano MA; Rimoin AW; Lusamba Dikassa PS
    Pragmat Obs Res; 2023; 14():155-165. PubMed ID: 38146546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine-derived polioviruses.
    Burns CC; Diop OM; Sutter RW; Kew OM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S283-93. PubMed ID: 25316847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021.
    Yang H; Qi Q; Zhang Y; Wen N; Cao L; Liu Y; Fan C; Yan D; Zhu X; Hao L; Zhu S; Ma Q; Liu J; Ma C; Nan L; Chen Y; Ma X; Chen N; Deng K; Shao G; Ding X; An Z; Rodewald LE; Li X; Wang D; Zhu H; Wang H; Feng Z; Xu W; Zhou J; Yin Z;
    JAMA Netw Open; 2023 Jan; 6(1):e2249710. PubMed ID: 36602797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
    Molodecky NA; Jafari H; Safdar RM; Ahmed JA; Mahamud A; Bandyopadhyay AS; Shukla H; Quddus A; Zaffran M; Sutter RW; Grassly NC; Blake IM
    Vaccine; 2023 Apr; 41 Suppl 1():A93-A104. PubMed ID: 34629206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.
    Wassilak S; Pate MA; Wannemuehler K; Jenks J; Burns C; Chenoweth P; Abanida EA; Adu F; Baba M; Gasasira A; Iber J; Mkanda P; Williams AJ; Shaw J; Pallansch M; Kew O
    J Infect Dis; 2011 Apr; 203(7):898-909. PubMed ID: 21402542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):357-62. PubMed ID: 19373195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.
    Shulman LM; Manor Y; Sofer D; Handsher R; Swartz T; Delpeyroux F; Mendelson E
    PLoS One; 2006 Dec; 1(1):e69. PubMed ID: 17183700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine-Derived Polioviruses, Central African Republic, 2019.
    Joffret ML; Doté JW; Gumede N; Vignuzzi M; Bessaud M; Gouandjika-Vasilache I
    Emerg Infect Dis; 2021 Feb; 27(2):620-623. PubMed ID: 33496226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis and implications of neurovirulent circulating vaccine-derived poliovirus in Jamaica. A case report and review of literature.
    Jackson ST; Mullings AM; Booth TF; MacDonald L; Henry SO; Khan CA; McLaughlin PD
    West Indian Med J; 2008 Nov; 57(5):511-4. PubMed ID: 19565986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laboratory surveillance for wild and vaccine-derived polioviruses--worldwide, January 2007-June 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(35):967-70. PubMed ID: 18772852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo.
    Voorman A; Hoff NA; Doshi RH; Alfonso V; Mukadi P; Muyembe-Tamfum JJ; Wemakoy EO; Bwaka A; Weldon W; Gerber S; Rimoin AW
    Vaccine; 2017 Oct; 35(42):5693-5699. PubMed ID: 28882442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020.
    Macklin GR; Goel AK; Mach O; Tallis G; Ahmed JA; O'Reilly KM; Grassly NC; Diop OM
    Vaccine; 2023 Apr; 41 Suppl 1():A19-A24. PubMed ID: 36008232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stopping a polio outbreak in the midst of war: Lessons from Syria.
    Mbaeyi C; Moran T; Wadood Z; Ather F; Sykes E; Nikulin J; Al Safadi M; Stehling-Ariza T; Zomahoun L; Ismaili A; Abourshaid N; Asghar H; Korukluoglu G; Duizer E; Ehrhardt D; Burns CC; Sharaf M
    Vaccine; 2021 Jun; 39(28):3717-3723. PubMed ID: 34053791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.